Hannan, Raquibul

The University of Texas Southwestern Medical Center

2 papers on CoChatORCID 0000-0003-1282-056X

Most cited papers

Verified
Type I IFN activating type I dendritic cells for antitumor immunity
Liang, Y., Hannan, R., & Fu, Y.-X. (2021) · Clinical Cancer Research
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 91
Verified
Immune-related adverse events are associated with improved outcomes in ICI-treated renal cell carcinoma patients.
Elias, R., Yan, F., Singla, N., Levonyack, N., Formella, J., Christie, A., Kapur, P., Bowman, A. I., Hammers, H. J., Hannan, R., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatment
Cited by 48

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free